Curcumin analog (EF24) could exert antiproliferative and anti-angiogenic effects on three ovarian cancer cells (SKOV-3, A2780, and OVCAR-3) in vivo via the downregulation of GLUT1-related glucose glycolysis, lactate production, and its upstream molecule HIF-1α (161). Here, SLC2A1 is linked to ovarian cancer.